Vitronectin XF™ vs Matrigel®

14 Jun 2022

Vitronectin XF™ vs Matrigel®: Bringing Standardization to Your Stem Cell Process Development

Below, we compare two leading cell attachment factors, Vitronectin XF – a xeno-free, single component ECM and Matrigel – a heterogeneous mix of non-human animal origin proteins and growth factors. Although both encourage cell proliferation and maintain pluripotency, only Vitronectin XF, a defined, FDA-friendly ECM, translates to simpler scale-up and accelerates the regulatory approval process for regenerative medicine and cell therapy applications.

You can download your own free digital copy here: Vitronectin XF vs Matrigel. To learn more about Vitronectin XF, please visit our product page.


Download Guide

Share this article

Brad N. Taylor, Ph.D.
Dr. Brad Taylor has 17 years of experience commercializing products for scientists in both academia and industry before joining Nucleus Biologics. Most recently, Dr. Taylor was the Director of Global Marketing at HemaCare, supporting the needs of the cellular therapy industry. Prior to HemaCare, Dr. Taylor spent 11 years at PerkinElmer supporting in vivo imaging platforms and has held leadership roles in technical support, product management, and marketing. Dr. Taylor holds a M.S. in Microbiology and Immunology from Louisiana State University Health Sciences Center and a Ph.D. in Molecular Biology and Genetics from Friedrich-Alexander University in Germany.